LOC105377136: A Potential Drug Target and Biomarker (G105377136)
LOC105377136: A Potential Drug Target and Biomarker
LOC105377136 is a gene that has been identified as a potential drug target or biomarker. The gene is located on chromosome 6 and encodes a protein known as LOC105377136.
LOC105377136 is a member of the known as the Kallikrein-related peptidases (KrP) family. This family of proteins is involved in the regulation of proteolysis, which is the breakdown of proteins by enzymes. KrP family proteins have been implicated in a number of diseases , including cancer, neurodegenerative diseases, and autoimmune disorders.
In addition to its potential drug target properties, LOC105377136 has also been identified as a potential biomarker for several diseases. For example, the KrP4 gene has been shown to be significantly upregulated in a variety of cancer types, including breast, ovarian, and prostate cancers . This suggests that LOC105377136 may be a useful biomarker for these cancers.
In addition to its potential clinical applications, LOC105377136 also has implications for basic research into the regulation of proteolysis and the role of KrP family proteins in disease. The continued study of LOC105377136 and its related genes may provide new insights into the mechanisms underlying disease and the development of new treatments.
Overall, LOC105377136 is a promising candidate for further research and potential drug development. While more work is needed to fully understand its potential and identify its clinical applications, its identification as a potential drug target and biomarker is a promising start.
Protein Name: Uncharacterized LOC105377136
The "LOC105377136 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105377136 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
LOC105377139 | LOC105377142 | LOC105377149 | LOC105377155 | LOC105377156 | LOC105377166 | LOC105377185 | LOC105377207 | LOC105377253 | LOC105377262 | LOC105377267 | LOC105377272 | LOC105377273 | LOC105377276 | LOC105377280 | LOC105377282 | LOC105377290 | LOC105377294 | LOC105377296 | LOC105377304 | LOC105377306 | LOC105377313 | LOC105377323 | LOC105377329 | LOC105377347 | LOC105377352 | LOC105377363 | LOC105377364 | LOC105377369 | LOC105377374 | LOC105377378 | LOC105377448 | LOC105377461 | LOC105377462 | LOC105377481 | LOC105377483 | LOC105377490 | LOC105377499 | LOC105377503 | LOC105377505 | LOC105377506 | LOC105377551 | LOC105377564 | LOC105377567 | LOC105377576 | LOC105377590 | LOC105377596 | LOC105377621 | LOC105377632 | LOC105377641 | LOC105377642 | LOC105377643 | LOC105377646 | LOC105377662 | LOC105377666 | LOC105377683 | LOC105377699 | LOC105377700 | LOC105377714 | LOC105377715 | LOC105377721 | LOC105377727 | LOC105377730 | LOC105377732 | LOC105377739 | LOC105377778 | LOC105377785 | LOC105377795 | LOC105377806 | LOC105377809 | LOC105377824 | LOC105377844 | LOC105377845 | LOC105377858 | LOC105377862 | LOC105377864 | LOC105377865 | LOC105377871 | LOC105377876 | LOC105377877 | LOC105377882 | LOC105377891 | LOC105377913 | LOC105377920 | LOC105377923 | LOC105377924 | LOC105377927 | LOC105377941 | LOC105377968 | LOC105377979 | LOC105377981 | LOC105377989 | LOC105378009 | LOC105378010 | LOC105378011 | LOC105378019 | LOC105378022 | LOC105378058 | LOC105378066 | LOC105378072
